A new study suggests nitrous oxide may offer a new treatment option for older adults with treatment-resistant depression.

A 2022 study showed that 28.3% of patients receiving ketamine had a billing diagnosis of depression. McLoughlin's group ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond ...

Researchers from Trinity College, St Patrick’s Mental Health Services, Queen’s University Belfast, Ireland, investigate use ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory ...

Discover ATAI’s pipeline, including promising BPL-003 for TRD, upcoming Phase 3 trials, and a merger with Beckley Psytech.

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...